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Inverse relationship between bioavailable testosterone
and subclinical coronary artery calcification in non-obese
Korean men
Byoung-Jin Park1, Jae-Yong Shim1, Yong-Jae Lee1, Jung-Hyun Lee2 and Hye-Ree Lee1
Although low testosterone levels in men have been associated with high risk for cardiovascular disease, little is known about the
association between male sex hormones and subclinical coronary disease in men with apparently low cardiometabolic risk. This study
was performed to investigate the association between male sex hormones and subclinical coronary artery calcification measured as
coronary calcium score in non-obese Korean men. We examined the relationship of total testosterone, sex hormone-binding globulin,
bioavailable testosterone and free testosteronewith coronary calciumscore in 291non-obeseKoreanmen (mean age: 52.869.3 years)
not having a history of cardiovascular disease. Using multiple linear regression, we evaluated associations between log (sex hormone)
levels and log (coronary calcium score) after adjusting for confounding variables in 105men with some degree of coronary calcification
defined as coronary calcium scoreo1. In multiple linear regression analysis, bioavailable testosterone was inversely associated with
coronary calcium score (P50.046) after adjusting for age, body mass index, smoking status, alcohol consumption, regular exercise,
mean blood pressure, resting heart rate, C-reactive protein, fasting plasma glucose, total cholesterol, triglyceride, high-density
lipoprotein (HDL) cholesterol, hypertension medication and hyperlipidemia medication, whereas total testosterone, sex
hormone-binding globulin and free testosterone were not (P50.674,P50.121 andP50.102, respectively). Our findings indicate that
bioavailable testosterone is inversely associated with the degree of subclinical coronary artery calcification in non-obese men.
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INTRODUCTION
Cardiovascular disease (CVD) is one of the leading causes of death
around the world, especially in developed countries.1 The impend-
ing aging of societies augments the importance of CVD as a factor
that both decreases the quality of life and increases the burden on
society.1 Thus, identification of risk factors for CVD and its early
detection may be important in providing a means to prevent or
slow its progression.2
A non-invasive marker of early coronary arterial wall alteration is
now available. The coronary calcium score (CCS) measured by multi-
detector computed tomography (MDCT) is a sensitive marker of
coronary artery atherosclerosis and reflects the severity of coronary
artery stenosis to some extent.2,3 Recent epidemiological evidence
suggests that CCS could help identify patients with cardiovascular
risks in addition to the Framingham risk score.4
An increasing body of evidence suggests that low testosterone levels
inmen are associated with high cardiovascular risk.5–7 Althoughmany
studies have been focused on the association between testosterone and
CVD events as well as mortality, and the free testosterone level has
been reported to be inversely associated with degree of coronary artery
disease in men with clinical coronary artery disease,8 little is known
about the association between sex hormones and subclinical coronary
disease in men with apparently low cardiometabolic risk.
Therefore, we examined the associations of male sex hormones with




We reviewed the medical records of 328 males who voluntarily parti-
cipated in a physical examination including male sex hormones and
MDCT at the Health Promotion Center of Gangnam Severance
Hospital, Yonsei University College of Medicine in Seoul, Korea,
between October 2007 and November 2008.
The inclusion criteria were community-dwelling men with body
mass index (BMI) below 25 kgm22, which is a cutoff value for general-
ized obesity in Asia.9 Subjects meeting any of the following criteria
were excluded (n537): a history of testosterone therapy and/or a
history of diabetes, angina pectoris, myocardial infarction or cerebro-
vascular diseases. After the exclusion, 291 participants were included
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in the final analysis. This study was approved by the Institutional
Review Board of Yonsei University College of Medicine in Korea.
The examinations were performed by medical staff according to
standard procedures. The participants were asked about lifestyle beha-
vior (including exercise, cigarette smoking and alcohol consumption)
and about ongoing treatment for any disease. If the participants were
under treatment, they were asked for the date of diagnosis and a list of
current medications. Trained staff reviewed the completed question-
naires and entered the responses into a database. The participants were
classified as non-smokers, ex-smokers or current smokers and were
categorized by alcohol consumption as non-drinkers or abstainers
(alcohol drinking ,140 g per week) and current drinkers (alcohol
drinkingo140 g per week). Regular exercise was defined asmore than
twice a week. Body weight and height were measured to the nearest
0.1 kg and 0.1 cm, respectively, with subjects wearing light indoor
clothing and no shoes. BMI was calculated as the ratio of weight to
height squared kg m22. Blood pressure and resting heart rate were
measured with the participants in the sitting position after 5 minutes
of rest using an automated device (TM-2665P; Analog&Digital Co.,
Ltd, Tokyo, Japan).
Blood samples were taken from the antecubital vein early in the
morning after a 12 h overnight fast. Fasting plasma glucose, total
cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride
and albuminweremeasured using aHitachi 7600-110 chemistry auto-
analyzer (Hitachi, Tokyo, Japan). C-reactive protein was measured
using a latex-enhanced immunoturbidimetric method.
Total testosterone and sex hormone-binding globulin (SHBG) con-
centrations were measured using an electrochemiluminescence assay
with a Modular Analytics E170 system (Roche Diagnostic Systems,
Basel, Switzerland). The mean interassay coefficient of variation was
3.8% for total testosterone and 1.9% for SHBG. Bioavailable testoster-
one (BT) and free testosterone (FT) were calculated using the compu-
terized Vermeulen formula,10 which is available on the International
Society For The Study of the Aging Male web site (http://www.
issam.ch).
CCS measurement
MDCT was performed to measure CCS (Philips Brilliance 64;
Philips Medical System, Best, The Netherlands). A 40–80 mg pro-
pranolol hydrochloride was administered orally 1 h before the
examination to reduce the heart rate in patients who had a heart
rate more than 65 beats per min. We used a prospective ECG-gating
protocol with a step-and-shoot technique. With the participants in
the supine position, MDCT scanning was performed in the cranio-
caudal direction within a single breath-hold at end-inspiratory
suspension. A 1.0 ml kg21 of iodinated contrast medium was admi-
nistered intravenously. Imaging was performed by using a real time
bolus tracking technique. The scans started 7 s after a trigger
threshold of 110 Hounsfield units was reached. The breath-hold
was achieved by all participants.
The image reconstruction was performed on the scanner’s work-
station using commercially available software (Extended Brilliance
Workstation; Philips Medical System). Reconstructed images were
analyzed for the presence and extent of coronary artery calcification
by using coronary calcium quantification software (Aquarius
Workstation; TeraRecon, Inc., Foster City, CA, USA). Total calcium
score of all patients was calculated with dedicated software and
expressed as Agatston scores. Agatston score is a commonly used
scoring method that calculates the total amount of calcium on the
basis of the number, areas, and peak Hounsfield units of the detected
calcified lesions.11
Statistical analysis
Demographic and biochemical characteristics of the study population
were described as percentages for categorical variables, and as the
mean6s.d. in the case of normal distribution and as median [25th
percentile to 75th percentile] or geometric mean6s.d. in the case of
non-normal distribution. In addition, we divided the subjects into two
groups as follows: the control (CCS50) and the coronary calcification
group (CCSo1). The basic characteristics of each group were com-
pared using the Student’s t-test for continuous variables and the
Table 1 Characteristics of the study population
Total Controls Coronary calcification P value
Number 291 186 105
Age (year) 52.869.3 49.567.6 58.769.3 ,0.001
Body mass index (kg m22) 22.961.6 23.061.5 22.861.8 0.394
Current smoker (%) 34.4 39.8 24.8 0.009
Alcohol consumptiona (%) 25.4 30.7 16.2 0.006
Regular exerciseb (%) 58.4 58.1 59.1 0.870
Systolic blood pressure (mmHg) 123.2614.2 121.9613.7 125.4615.0 0.046
Diastolic blood pressure (mmHg) 77.868.7 77.068.4 79.169.2 0.047
Fasting plasma glucose (mg dl21) 95.5619.9 93.1618.3 99.7622.0 0.009
Total cholesterol (mg dl21) 191.4635.1 191.4635.3 191.5634.8 0.975
HDL-cholesterol (mg dl21) 49.7610.8 50.2611.1 48.8610.1 0.286
Triglyceride (mg dl21) 122.5662.0 119.7659.2 127.4666.7 0.307
C-reactive protein (mg l21) 2.265.7 2.566.7 1.763.0 0.145
Albumin (g dl21) 4.760.3 4.760.3 4.760.3 0.329
Male sex hormones (nmol l21)
Total testosterone 17.0 [13.7–20.5] 17.1 [13.6–20.6] 16.9 [13.9–20.3]
Sex hormone-binding globulin (SHBG) 40.7 [31.9–51.2] 38.3 [29.7–48.0] 43.7 [34.0–53.9]
Bioavailable testosterone (BT) 7.29 [5.97–9.26] 7.42 [6.32–9.85] 6.89 [5.72–8.40]
Free testosterone (FT) 0.29 [0.24–0.36] 0.29 [0.25–0.38] 0.28 [0.23–0.33]
Abbreviation: HDL-cholesterol, high-density lipoprotein-cholesterol.
Data are expressed as themean6s.d., proportions ormedian [25th percentile to 75th percentile] for skewed variables. P values were calculated with t-test or Chi-square test.
a Alcohol drinkingo140 g per week.
b Regular exerciseotwice per week.
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chi-square test for categorical variables. Univariate regression analysis
was performed to measure the strength of the relationship between
coronary calcification and surrogate markers for CVD. Among sub-
jects with coronary calcification, associations between sex hormone
levels andCCSwere evaluated usingmultiple linear regression analysis
with CCS being a continuous variable after log-transformation of sex
hormones and CCS. All analyses were conducted using SAS statistical
software, version 9.1 (SAS Institute Inc, Cary, NC, USA). All statistical
tests were two-sided, and statistical significance was determined with a
P value ,0.05.
RESULTS
The mean subject age was 52.869.3 years. The median serum concen-
tration of total testosterone was 17.0 nmol l21, SHBG was 40.7 nmol
l21, BT was 7.29 nmol l21 and FT was 0.29 nmol l21. The geometric
mean CCS was 36.665.0, which was calculated using the following
equation: exp [mean (log CCS)]. All male sex hormones and CCSwere
positively skewed. Age, systolic blood pressure, diastolic blood pres-
sure and fasting plasma glucose were higher in the group with cor-
onary calcification (P,0.001, P50.046, P50.047 and P50.009,
respectively). The mean BMI was similar in both groups. The percent-
age of current smokers and alcohol consumption was higher in the
control group (P50.009 and P50.006, respectively) (Table 1).
According to univariate analysis, old age, high blood pressure, high
fasting plasma glucose, high SHBG, lowBT and low FTwere associated
with coronary artery calcification, whereas total testosterone was not
(Table 2). Upon multivariate linear regression analysis, BT and FT
were found to be independently and inversely related with CCS after
adjusting for age and BMI, whereas total testosterone and SHBG were
not. We also assessed associations between male sex hormones and
CCS after additional adjustment for smoking status, alcohol con-
sumption, regular exercise, mean blood pressure, resting heart rate,
C-reactive protein, fasting plasma glucose, total cholesterol, triglycer-
ide, high-density lipoprotein-cholesterol, hypertension medication
and hyperlipidemia medication. These inverse and independent asso-
ciations remained for BT after using model 3 (Table 3).
DISCUSSION
In this cross-sectional study, BT was inversely associated with the
degree of subclinical coronary artery calcification in non-obese men
without clinical CVD but with some degree of coronary calcification.
A decreased testosterone level has been found to be predictive of
subclinical atherosclerosis in some observational studies. Most studies
were performed to determine the relationship between testosterone
and carotid artery intima-media thickness12–14 or abdominal aortic
calcification.15 To our knowledge, there was only one previous study16
that focused on the association between sex hormone and subclinical
coronary calcification. Ouyang et al.16 reported that testosterone is
associated with coronary calcium score, but the study was conducted
only on postmenopausal women.
Although the reason for the relationship between BT and CCS is
unclear, it may be explained by some biological mechanisms.
Endothelial dysfunction has been linked to testosterone deficiency.
There are two possible mechanisms for this relationship: direct and
indirect mechanisms. For the former, testosterone has positive effects
on endothelial function by directly stimulating endothelium-derived
nitric oxide.17,18 Additionally, testosterone could stimulate endothelial
progenitor cells, which plays a key role in endothelial repair.19,20 Lu
et al.21 have proposed that decreased testosterone is associated with
ultrastructural damage of the aortic endothelium. In this regard, hypo-
gonadism has been reported to contribute to the development of
metabolic syndrome.22–24 Metabolic syndrome represents a cluster of
cardiometabolic risk factors, including central obesity, elevated blood
pressure, impaired glucose metabolism and atherogenic dyslipidemia.
Thus, a low testosterone level could have an indirect deleterious effect
on endothelium through induction of the metabolic syndrome. The
relatively low cardiometabolic risk of the subjects in the present study
suggests that the level of BT may affect the coronary arteries indepen-
dently of the metabolic syndrome.
Our results demonstrate that FT was associated with the severity of
CCS independently of age and BMI (P50.042), but not of other tra-
ditional CVD risk factors including blood pressure and fasting plasma
Table 2 Univariate analysis of factors associated with coronary artery
calcification
Variables Odds ratio (95% CI) P value
Age (year) 1.14 (1.10–1.18) ,0.001
Body mass index (kg m22) 0.93 (0.81–1.08) 0.364
Systolic blood pressure (mmHg) 1.02 (1.00–1.04) 0.048
Diastolic blood pressure (mmHg) 1.03 (1.00–1.06) 0.048
Fasting plasma glucose (mg dl21) 1.02 (1.00–1.03) 0.011
Total cholesterol (mg dl21) 1.00 (0.99–1.01) 0.975
HDL-cholesterol (mg dl21) 0.99 (0.97–1.01) 0.286
Triglyceride (mg dl21) 1.00 (0.99–1.01) 0.307
C-reactive protein (mg l21) 0.97 (0.91–1.03) 0.250
Total testosteronea (nmol l21) 0.93 (0.46–1.89) 0.845
Sex hormone-binding globulina (SHBG) (nmol l21) 2.47 (1.33–4.60) 0.004
Bioavailable testosteronea (BT) (nmol l21) 0.44 (0.21–0.92) 0.030
Free testosteronea (FT) (nmol l21) 0.42 (0.20–0.89) 0.024
Abbreviation: HDL-cholesterol, high-density lipoprotein-cholesterol.
a Values have been analyzed after log-transformation. P values were calculated with
univariate logistic regression analysis.
Table 3 Multiple regression analysis showing the independent contribution of sex hormones to coronary artery calcification in non-obese men
with some degree of coronary calcification defined as coronary calcium scoreo1
Model 1 Model 2 Model 3
b6s.e.b P value b6s.e.b P value b6s.e.b P value
Total testosteronea (nmol l21) 20.71360.535 0.186 20.59660.517 0.252 20.22560.535 0.674
Sex hormone-binding globulina (SHBG) (nmol l21) 0.94560.496 0.059 0.36560.540 0.501 0.90860.579 0.121
Bioavailable testosteronea (BT) (nmol l21) 21.83060.498 ,0.001 21.33060.548 0.017 21.15760.572 0.046
Free testosteronea (FT) (nmol l21) 21.67460.532 0.002 21.15660.563 0.042 20.98360.595 0.102
a Values have been analyzed after log-transformation.
bUnits of beta are log-unit increased coronary calcium score per 1 log unit greater sex hormone level. Model 1: unadjusted. Model 2: adjusted for age and body mass index.
Model 3: adjusted for age, bodymass index, smoking status, alcohol intake, exercise,mean blood pressure, resting heart rate, C-reactive protein, fasting plasma glucose, total
cholesterol, triglyceride, HDL-cholesterol, hypertension medication and hyperlipidemia medication.
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glucose (P50.102). Although all blood samples were drawn early in
the morning tominimize the diurnal variation in testosterone levels,25
FT might be less reliable rather than BT to represent basal androgenic
activity.
However, our study has some limitations. First, our study is a
cross-sectional study, and the cause–effect relationship between
male sex hormones and CCS remains unclear. Second, we used
calculated rather than directly measured BT and FT. Third, our
results cannot be generalized to women. Fourth, the study popu-
lation may not be representative of the general population of Korea
because the study subjects were volunteers who visited a single
hospital for physical check-up. Therefore, this study may have been
affected by the selection bias. In this regard, the prevalence of
current smoker was lower in subjects with coronary calcification.
Fifth, only one sex hormone measurement was included in the
analysis because the current study was based on the retrospective
review. Therefore, we did not provide the intra-assay coefficient of
variation. Lastly, bioavailable testosterone was inversely related to
coronary calcification, but only in those with some degree of cor-
onary calcification. Hence, the relevance of bioavailable testoster-
one to initiation of coronary calcification has not been addressed in
this study.
In conclusion, our findings indicate that BT is inversely associated
with subclinical coronary artery calcification in non-obese men with-
out clinical CVD but with some degree of coronary calcification.
Accordingly, early detection of decreased BT is important in the
assessment of potential cardiovascular risk and could be an initiative
for CVD prevention and vascular health management.
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